risk management

China Pacific Insurance’s conservative pivot strengthens earnings: S&P

It has reduced its high-risk asset holdings from 48% to 24% of its investment portfolio.

China Pacific Insurance’s conservative pivot strengthens earnings: S&P

It has reduced its high-risk asset holdings from 48% to 24% of its investment portfolio.

Taiwan insurers to raise fresh equity amidst new capital requirement 

The new standard also raised compliance risks for insurers.

Insurers rank regulatory changes, geopolitics as top risks

APAC insurers anticipate high inflation and strong economic resilience.

Allianz Australia's capital adequacy to remain strong

Thanks to removal of certain non-life liability adjustments, deferred acquisition cost deductions.

APAC insurers trim equity risks, increase capital efficiency: Moody's

APAC P&C insurers face different risks compared to their US counterparts. 

Sumitomo Life strong despite investment pressures: Fitch Ratings

Its underwriting profitability recovered, with core profit margin at 12%.

Beneficial Insurance boasts 36.1% return on equity

Beneficial’s risk-adjusted capitalisation was strongest level as of 31 March.

GIC Re maintains strong capitalisation in FY 2024

In FY 2024, the company reported a consolidated ROE of 9.5%.

China Taiping set to maintain strong market position

The group reported $10.51b in outstanding debt as of June, down from $11.90b last year.

Nat Re benefits from robust local insurer ties 

In 2023, Nat Re saw a notable rise in net profit, driven by improved underwriting.

Samsung Fire & Marine holds robust balance sheet, leads in auto insurance

SFM maintains the highest regulatory solvency ratio amongst non-life insurers in South Korea

Sumitomo Life's capital remains solid despite solvency ratio decline

Sumitomo Life’s core profit margin increased to 12%.

Lloyd’s projects $14.5t loss from hypothetical global conflict

The scenario highlights the vulnerability of global trade.

Meiji Yasuda Life’s core profit up 27% from strong sales

The weaker yen against the US dollar also boosted profits.

UniMed’s capitalisation hits strongest level in 2023

Thanks to low underwriting leverage and moderate investment risk.